Interactions between monoamines, glutamate, and GABA in schizophrenia: New evidence

被引:536
作者
Carlsson, A [1 ]
Waters, N [1 ]
Holm-Waters, S [1 ]
Tedroff, J [1 ]
Nilsson, M [1 ]
Carlsson, ML [1 ]
机构
[1] Univ Gothenburg, Inst Physiol & Pharmacol, Gothenburg, Sweden
关键词
dopamine; noradrenaline; serotonin; movement disorders; stabilization;
D O I
10.1146/annurev.pharmtox.41.1.237
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In spite of its proven heuristic value, the dopamine hypothesis of schizophrenia is now yielding to a multifactorial view, in which the other monoamines as well as glutamate and GABA are included, with a focus on neurotransmitter interactions in complex neurocircuits. The primary lesion(s) in schizophrenia does not necessarily involve any of these neurotransmitters directly but could deal with a more general defect, such as a faulty connectivity of developmental origin. Nevertheless, a precise identification of neurotransmitter aberrations in schizophrenia will probably provide clues for a better understanding of the disease and for the development of new treatment and prevention strategies.
引用
收藏
页码:237 / 260
页数:24
相关论文
共 47 条
[1]  
Abi-Dargham A, 1998, AM J PSYCHIAT, V155, P761
[2]   LOW BRAIN UPTAKE OF L-[C-11]5-HYDROXYTRYPTOPHAN IN MAJOR DEPRESSION - A POSITRON EMISSION TOMOGRAPHY STUDY ON PATIENTS AND HEALTHY-VOLUNTEERS [J].
AGREN, H ;
REIBRING, L ;
HARTVIG, P ;
TEDROFF, J ;
BJURLING, P ;
HORNFELDT, K ;
ANDERSSON, Y ;
LUNDQVIST, H ;
LANGSTROM, B .
ACTA PSYCHIATRICA SCANDINAVICA, 1991, 83 (06) :449-455
[3]   FUNCTIONAL ARCHITECTURE OF BASAL GANGLIA CIRCUITS - NEURAL SUBSTRATES OF PARALLEL PROCESSING [J].
ALEXANDER, GE ;
CRUTCHER, MD .
TRENDS IN NEUROSCIENCES, 1990, 13 (07) :266-271
[4]   Emerging principles of altered neural circuitry in schizophrenia [J].
Benes, FM .
BRAIN RESEARCH REVIEWS, 2000, 31 (2-3) :251-269
[5]   Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method [J].
Breier, A ;
Su, TP ;
Saunders, R ;
Carson, RE ;
Kolachana, BS ;
de Bartolomeis, A ;
Weinberger, DR ;
Weisenfeld, N ;
Malhotra, AK ;
Eckelman, WC ;
Pickar, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) :2569-2574
[6]  
BUNNEY BG, 1995, CLIN NEUROSCI, V3, P81
[7]  
BUNNEY BG, 1995, PSYCHOPHARMACOLOGY 4, P1203
[8]   Network interactions in schizophrenia - therapeutic implications [J].
Carlsson, A ;
Waters, N ;
Waters, S ;
Carlsson, ML .
BRAIN RESEARCH REVIEWS, 2000, 31 (2-3) :342-349
[9]   Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications [J].
Carlsson, A ;
Hansson, LO ;
Waters, N ;
Carlsson, ML .
LIFE SCIENCES, 1997, 61 (02) :75-94
[10]   THE CURRENT STATUS OF THE DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA [J].
CARLSSON, A .
NEUROPSYCHOPHARMACOLOGY, 1988, 1 (03) :179-186